Mugwagwa, Tendai http://orcid.org/0000-0001-7515-8548
Stagg, Helen R. http://orcid.org/0000-0003-4022-3447
Abubakar, Ibrahim http://orcid.org/0000-0002-0370-1430
White, Peter J. http://orcid.org/0000-0002-6644-3512
Article History
Received: 29 August 2017
Accepted: 13 December 2017
First Online: 23 January 2018
Competing Interests
: H.R.S. and P.J.W. have received research funding from Otsuka SA for an audit of multidrug-resistant tuberculosis treatment in several eastern European countries. A study (ISRCTN04379941) on which H.R.S. is a co-applicant has received free drugs from Sanofi for a randomised controlled trial of the treatment of latent tuberculosis. H.R.S. has also previously received travel expenses from the World Health Organization to attend a meeting on latent tuberculosis.